| Literature DB >> 31336705 |
Linda Holmström1, Ann-Christin Eliasson2, Rita Almeida3,4, Catarina Furmark1, Ann-Louise Weiland5, Kristina Tedroff1,5, Kristina Löwing1,5.
Abstract
The objective was to evaluate the effects of the Small Step Program on general development in children at risk of cerebral palsy (CP) or other neurodevelopmental disorders. A randomized controlled trial compared Small Step with Standard Care in infants recruited at 4-9 months of corrected age (CA). The 35-week intervention targeted mobility, hand use, and communication during distinct periods. The Peabody Developmental Motor Scales2ed (PDMS-2) was the primary outcome measure. For statistical analysis, a general linear model used PDMS-2 as the main outcome variable, together with a set of independent variables. Thirty-nine infants were randomized to Small Step (n = 19, age 6.3 months CA (1.62 SD)) or Standard Care (n = 20, age 6.7 months CA (1.96 SD)). Administering PDMS-2 at end of treatment identified no group effect, but an interaction between group and PDMS-2 at baseline was found (p < 0.02). Development was associated with baseline assessments in the Standard Care group, while infants in the Small Step group developed independent of the baseline level, implying that Small Step helped the most affected children to catch up by the end of treatment. This result was sustained at 2 years of age for PDMS-2 and the PEDI mobility scale.Entities:
Keywords: cerebral palsy; communication; development; early intervention; gross motor function; other neurological disorder; upper limb function
Year: 2019 PMID: 31336705 PMCID: PMC6679038 DOI: 10.3390/jcm8071016
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Figure 1Flow diagram of data collection procedure.
Baseline demographic characteristics of the participants (n = 39).
| Small Step ( | Standard Care ( | ||
|---|---|---|---|
|
| |||
| Gestational age, weeks, mean (SD) | 33 (6.5) | 33 (6.95) | |
| Inclusion CA age (T0), months, mean (SD) | 6.3 (1.62) | 6.7 (1.96) | |
| Gender, male/female | 12/7 | 14/6 | |
|
| |||
| Extreme premature/preterm/term | 6/5/8 | 8/3/9 | |
| AIMS (raw score) (T0) | 18.0 (6.87) | 19.52 (7,58) | |
| HINE (T0) | |||
| Twins, | 4 (3) | 3 (2) | |
| MRI, available | 13 | 16 | |
|
| |||
| Therapist-led treatment hours, mean | 28 | 16 | |
| Weeks included in study (T0–T5), mean (SD) | 43.5 (5.88) | 41.7 (5.23) | |
| First-born child | 10 | 10 | |
| HADS, T0, frequency, d depression/no depression (missing) | 7/11 | 3/12 (4) | |
| HADS, T0, frequency, anxiety/no anxiety (missing) | 8/10 | 3/12 (4) | |
| HADS, total mean, SD | 13.5 (8,53) | 10.4 (7.0) | |
Abbreviations: CP = cerebral palsy; CA = Corrected age for children born before week 37, extreme premature <29 weeks, preterm 29–36 weeks; AIMS = Alberta Infant Motor Scale, HINE = Hammersmith Infant Neurological Examination; HADS = Hospital Anxiety and Depression Scale, a Wilcoxon, b Chi-square, c two-sample t-test, d using the cut-off of 8.
Means and 95% confidence intervals for the Peabody Developmental Motor Scales2ed (PDMS, raw score), Gross Motor Function Measure-66 (GMFM-66), Pediatric Evaluation of the Disability Inventory (PEDI, functional scale, scaled score), and Bayley Scales of Infant Development III (BSID, index score).
| Assessment | Small Step, | Standard Care, | ||||
|---|---|---|---|---|---|---|
| T0 | T5 | 2 Years | T0 | T5 | 2 Years | |
| PDMS, Stat | 21.9 | 35 | 39.22 | 23.5 | 33.8 | 34.9 |
| PDMS, Loc | 19.7 | 58 | 70.83 | 20.4 | 58.8 | 71.7 |
| PDMS, Gr | 17.5 | 36 | 38.94 | 17.89 | 34.78 | 37.47 |
| PDMS, Vm | 20 | 59.6 | 72 | 20.68 | 53.89 | 71.15 |
| GMFM-66 | 27.7 | 48.4 | 52.9 | 29.2 | 48.6 | 54.0 |
| PEDI, SC | 36.4 | 32.2 | 37.7 | 27.2 | ||
| PEDI, Mob | 43.2 | 47.9 | 37.7 | 44.5 | ||
| PEDI, Soc | 24.67 | 43.2 | 21.11 | 41.2 | ||
| BSID, Cog | 84 | 81 | ||||
| BSID, Lang | 82 | 82 | ||||
| BSID, Mot | 74 | 75 | ||||
Stat = Stationary, Loc = locomotion, Gr = grasp, Vm = visuomotor integration, SC = self care, Mob = mobility, Soc = social function, Cog = cognitive development, Lang = receptive and expressive language development, Mot = fine and gross motor development.
Final linear model analysis with PDMS-2 as the outcome at post intervention (T5) and at 2 years of age (T6). The models for secondary outcomes, GMFM-66, and the PEDI mobility scale are also reported.
| T5, After Intervention | T6, 2-Year Follow-Up | |||||||
|---|---|---|---|---|---|---|---|---|
| Mean PDMS-2 | GMFM-66 * | Mean PDMS-2 | PEDI Mobility | |||||
| Reg. Coeff. | Reg. Coeff. | Reg. Coeff. | Reg. Coeff. | |||||
| Small Step/Standard Care | 18.271 |
| 18.977 |
| 21.497 |
| 15.666 |
|
| PDMS-2, T0 | 1.525 |
| 0.929 |
| 1.403 |
| 1.284 |
|
| HINE, T0 | 0.289 |
| 0.208 |
| 0.297 | 0.09 | 0.231 | 0.07 |
| Time, T0–T5 | 0.416 | 0.07 | 0.251 | 0.13 | 0.159 | 0.576 | 0.0297 | 0.89 |
| Inclusion age | –1.532 | 0.16 | –0.830 | 0.33 | –1.954 | 0.167 | –2.420 |
|
| GMFCS/2 groups | −9.522 | 0.26 | −13.305 |
| −15.540 |
| −17.482 |
|
| −0.839 |
| −0.621 |
| −1.095 |
| −0.750 |
| |
* When GMFM-66 was used at T5, PDMS-2 was replaced with GMFM-66 at T0 in the mode.
Figure 2A general linear model showing that the group effect on mPDMS-2 after intervention (T5) depended on the baseline (T0) values (interaction, p = 0.02). Data are represented in black for Small Step and grey for Standard Care.
Diagnostic information on participants, collected at 2 years of age.
| Small Step ( | Standard Care ( | |
|---|---|---|
|
| ||
| Bilateral CP | 5 | 6 |
| Unilateral CP | 0 | 1 |
| Dyskinetic CP | 3 | 2 |
| Ataxic CP | 1 | 0 |
| Unspecific CP | 1 | 1 |
| Malformation syndrome | 1 | 0 |
| Autism spectrum disorder | 1 | 0 |
| Other neurodevelopmental disorder | 6 | 8 |
| Delayed development | 1 | 0 |
| Typical development | 1 | 1 |
|
| ||
| Epilepsy | 6 | 2 |
| Visual impairment | 3 | 4 |
| Hearing impairment (cochlea, | 1 | 2 |
| Hydrocephalus, shunt | 3 | 3 |
| High comorbidity * | 6 | 3 |
|
| ||
| Grey matter injury | 1 | 2 |
| White matter damage of immaturity | 5 | 7 |
| Maldevelopment | 2 | 2 |
| Miscellaneous | 4 | 0 |
| No visual deviation | 1 | 5 |
| Missing | 6 | 3 |
|
| ||
| Level 1:2 | 8/2 | 12/3 |
| Level 3:4:5 | 6/0/3 | 2/1/2 |
|
| ||
| Level 1:2 | 5/7 | 13/1 |
| Level 3:4:5 | 4/1/2 | 2/1/2 |
* High comorbidity defined as three or more co-diagnoses.
The following questions were included in the parental questionnaire concerning the feasibility and acceptability of the program.
| Questions (Scored 1–9) * | Small Step ( | Standard Care ( |
|---|---|---|
| Based on your experience of the intervention, how useful do you find this kind of treatment? | 8.6 | 6.4 |
| To what extent do you think the intervention/follow-up has affected the pace of your infant’s development? | 8.2 | 6.5 |
| What is your overall experience of the attitude and approach of the staff towards you and your family? | 8.6 | 9 |
| How important was answering the questions on parental wellbeing? | 6.7 | 6 |
| How useful were the hospital assessments of your child? | 8.3 | 7.5 |
| Do you feel you received sufficient feedback from us on the assessments of your child’s development? | 7.6 | 7.5 |
| How likely is it that you would recommend this treatment to a friend with an infant with developmental delay? | 8.8 | |
| Rate your motivation to participate in this training programme. | 8.3 | |
| During treatment, training was conducted for one developmental domain at a time: gross motor skills, communication, and fine motor skills. To what extent do you think that training each domain separately was an advantage (high value) or a disadvantage (low value)? | 8.1 | |
| You met several staff with different backgrounds, knowledge, and expertise. To what degree do you rate this as an advantage (high value) or a disadvantage (low value)? | 8.2 |
* 1 = using words such as: not at all, not good, not everyone, and disadvantage; 9 = using words such as: to a large extent and advantage.